Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer
Clinical trial NCT02446405 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02446405
- Sponsor
- University of Sydney
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2026-12-31
- Enrollment
- 1125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.